14-3-3 σ possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid

被引:13
作者
Ito, Y
Miyoshi, E
Uda, E
Yoshida, H
Uruno, T
Takamura, Y
Miya, A
Kobayashi, K
Matsuzuka, F
Matsuura, N
Kakudo, K
Kuma, K
Miyauchi, A
机构
[1] Kuma Hosp, Chuo Ku, Kobe, Hyogo 6500011, Japan
[2] Kuma Hosp, Dept Biochem, Chuo Ku, Kobe, Hyogo 6500011, Japan
[3] Osaka Univ, Sch Allied Hlth Sci, Fac Med, Dept Pathol, Suita, Osaka 5650871, Japan
[4] Wakayama Med Coll, Dept Pathol, Wakayama 6400012, Japan
关键词
14-3-3; sigma; thyroid carcinoma; immunohistochemistry;
D O I
10.1016/S0304-3835(03)00129-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Jun activation domain-binding protein 1 (jab1) is known as a coactivator of the AP1 transcription factor. Recent studies have demonstrated that jab1 contributes to carcinoma progression by degrading p27/Kip1 protein. In this study, we immunohistochemically investigated jab1 expression in thyroid neoplasms. jab1 overexpression tended to be frequently observed in follicular carcinoma compared to adenoma. Larger-sized papillary carcinoma overexpressed jab1 in higher incidence than microcarcinomas (1.0 cm or less in maximum diameter). In anaplastic carcinoma, jab1 was more frequently overexpressed than in papillary and follicular carcinomas. An inverse relationship was detected between jab1 overexpression and p27 expression in papillary and anaplastic carcinomas, but not in follicular tumor. These results suggest that jab1 plays a role in the progression of thyroid carcinomas, especially those of aggressive phenotypes, and it may be responsible for p27 degradation in anaplastic and papillary carcinomas. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 23 条
[1]  
ALDINGER KA, 1978, CANCER-AM CANCER SOC, V41, P2267, DOI 10.1002/1097-0142(197806)41:6<2267::AID-CNCR2820410627>3.0.CO
[2]  
2-7
[3]  
[Anonymous], 1988, HISTOLOGIC TYPES THY
[4]   Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo [J].
Battista, S ;
de Nigris, F ;
Fedele, M ;
Chiappetta, G ;
Scala, S ;
Vallone, D ;
Pierantoni, GM ;
Megar, T ;
Santoro, M ;
Viglietto, G ;
Verde, P ;
Fusco, A .
ONCOGENE, 1998, 17 (03) :377-385
[5]   A new group of conserved coactivators that increase the specificity of AP-1 transcription factors [J].
Claret, FX ;
Hibi, M ;
Dhut, S ;
Toda, T ;
Karin, M .
NATURE, 1996, 383 (6599) :453-457
[6]  
Erickson LA, 1998, MODERN PATHOL, V11, P169
[7]  
FAGIN JA, 2000, THYROID, P886
[8]  
FRANCESCHI S, 1993, CRIT REV ONCOGENESIS, V4, P25
[9]   An immunohistochemical analysis of cyclin D1, p53. and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland [J].
Goto, A ;
Sakamoto, A ;
Machinami, R .
PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (04) :217-222
[10]  
HEDLIN NE, 1999, MOL CELL ENDOCRINOL, V153, P79